Immune monitoring of trabectedin therapy in refractory soft tissue sarcoma patients – the IMMUNYON study
Soft tissue sarcomas (STS) encompass over 50 histologic subtypes, representing more than 1% of solid tumors. Standard treatments include surgical resection and therapies such as anthracyclines or trabectedin for advanced cases, though challenges persis…